UB-102

N/A

Report date: 2025/12/12 16:39:20

Base Information

Drug NameUB-102
Drug Alias NameUB102UB-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionVascular endothelial growth factor A modulatorsAngiopoietin-2 modulators
TargetsVascular endothelial growth factor AAngiopoietin-2
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesUni-Bio Science Group
China Registration ClassN/A

Develop Information

Active CompaniesUni-Bio Science Group
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A